Vaccines serve as the cornerstone for the prevention and control of infectious diseases, as well as for establishing herd immunity barriers. Spanning the spectrum from traditional inactivated and attenuated vaccines to next-generation technologies—such as recombinant protein, viral vector, and mRNA vaccines—Begrand provides integrated process systems designed for efficient cell expansion, virus culture, antigen purification, concentration, and sterile processing to support both vaccine R&D and large-scale manufacturing. Our equipment strictly adheres to GMP standards, balancing high yield, exceptional stability, and uncompromising safety to facilitate the rapid industrialization of both prophylactic and innovative therapeutic vaccines, thereby empowering our clients to achieve breakthroughs in critical fields such as influenza, HPV, COVID-19, and oncology vaccines.